fbpx
  • Home
  • Study Details
Open

Prostate Cancer Treatment Decisions for Black Patients

The purpose of this research study is to better understand, from the perspective of Black patients, whether telemedicine visits make prostate cancer decision making easier or harder. The COVID-19 pandemic made it more difficult for patients to see their doctors, but care could continue by having appointments via a computer or phone, which many prostate cancer doctors used. Whether in person or remote, successfully choosing a treatment for prostate cancer often uses shared decision making (SDM), the process where doctors and patients work together to make decisions that match what matters to patients, but it is unknown whether virtual appointments make discussions better or worse. Other studies have shown that Black patients may be less satisfied with their treatment choices than non-Black patients. Therefore, it is important that we understand how to improve the same quality of care for Black patients.

Age & Gender

  • 18 years ~ 99 years
  • Male, Gender Inclusive

Location

North Carolina (Statewide), South Carolina

What will be asked of you

If you agree to take part in this research, you will participate in a video/audio or telephone interview designed to capture opinions about your experience with treatment decision making and the visits with your doctors. You will also answer questions about your demographics. This interview will take about 60-90 minutes.

Incentives

$50 VISA gift card, Participants will be given the option to receive summary results upon study completion.

Total length of participation:
Approximately 3 hours

Looking for Specific Volunteers

Able to participate:

  • Identify as Black (including African American/African Ancestry)
  • Have been diagnosed with localized prostate cancer
  • Had your initial prostate cancer treatment consultation in or after April 2020 at a UNC clinic

Not eligible if:

  • Do not identify as Black (including African American/African Ancestry)
  • Have been diagnosed with metastatic prostate cancer
  • Had you initial prostate cancer treatment consultation before April 2020 or not at a UNC clinic

Contact the Team

Visit Location

100% Remote (online, phone, text)

Additional Study Information

Principal Investigator

Shekinah Elmore
Lineberger Comprehensive Cancer Center

Study Type

Clinical or Medical
Observational

Study Topics

Cancer (Prostate)
Minority Health
Opinions and Perceptions
Men's Health
COVID-19

IRB Number

21-1226

logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research
Research for Me logo

Copyright © 2013-2020 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.